2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Hematology
Concurrent

Blood Matters: Everything Needed to Understand Transfusion and Anemia Management in Your ICU

Tuesday, March 24, 2026
3:45 PM - 4:45 PM Central Time
Location: W187

Blood transfusion remains a cornerstone of resuscitation in the ICU, yet recent advancements in evidence-based medicine, precision transfusion, and alternative strategies are reshaping critical care. This session will provide cutting-edge insights on the optimal use of blood products, regulatory considerations across global healthcare systems, and innovative strategies for managing patients who decline transfusion. Speakers will discuss emerging therapies, machine learning applications in transfusion decision-making, and advanced blood conservation techniques. This session will prepare clinicians to apply the latest transfusion science and technology, as well as bloodless medicine management in everyday ICU practice. Speakers will explore novel biomarkers for earlier diagnosis of anemia, AI-driven decision support, preventative measures, specific transfusion thresholds, and emerging alternatives to traditional blood products for treatment of anemia. State-of-the-art diagnostic modalities, pharmacologic and blood conservation strategies, and the future of synthetic blood products will also be discussed.

Learning Objectives:

  • Differentiate between traditional and emerging biomarkers, including hepcidin and hypoxia-inducible factors, for diagnosing and managing ICU anemia
  • Explore innovative blood conservation and nontransfusion strategies, including erythropoiesis-stimulating agents, IV iron, and hemostatic agents
  • Analyze the latest AI-driven transfusion algorithms and their role in optimizing blood product use in critically ill patients
  • Discuss the integration of novel noninvasive monitoring technologies, such as near-infrared spectroscopy and AI-enhanced perfusion assessment, into ICU transfusion decision-making
  • Examine new developments in blood alternatives, including synthetic hemoglobin-based oxygen carriers and stem-cell-derived products

Presentations:

  • 3:50 PM - 4:05 PM Central Time
    Whole Blood Revival: The Evolution of Transfusion Strategies

    Firas Madbak, MD, FCCM (he/him/his) – UF Health Jacksonville

  • 4:05 PM - 4:20 PM Central Time
    Synthetic Blood and Beyond: The Future of Transfusion Medicine Is Here

    Allan Doctor, MD (he/him/his) – University of Maryland School of Medicine

  • 4:20 PM - 4:35 PM Central Time
    AI Meets Hemoglobin: Machine Learning in Transfusion Medicine

    Teresa Rincon, BSN, PhD, FCCM